BioSpace News Archive

Schrödinger, Inc. and the Tri-Institutional Therapeutics Discovery Institute, Inc.have renewed and extended, for an additional five years, an agreement reached in 2014 to provide access to Schrödinger’s Materials Science, Biologics, and Small?Molecule Drug Discovery Suites to researchers within TRI-I TDI’s member institutions.

Enterprise Therapeutics Ltd announced that it has closed an oversubscribed £29 million ($41 million USD) Series B round co-led by Versant Ventures and Novartis Venture Fund. The syndicate also included new investor Forbion, founding investor Epidarex Capital and existing investor IP Group.

BioPharma Services, Inc. is honored to announce the addition of Dr. John Oldenhof, PhD, and Dr. Isabella Szeto, MD, CCFP, FCFP, CPI, to the Senior Management team here at BioPharma.

Seattle Genetics, Inc. announced data highlights from nine presentations showcasing the company’s innovative, proprietary antibody-drug conjugate (ADC) platform technologies as well as its emerging immuno-oncology pipeline.

Gritstone Oncology announced that preclinical data highlighting the company’s tumor-specific neoantigen (TSNA) identification platform, EDGETM (Epitope Discovery in cancer GEnomes), and a novel, potent TSNA delivery approach will be presented during two poster presentations at the 2018 American Association for Cancer Research (AACR) Annual Meeting.

Multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety profiles of weekly CAN008 + re-radiation therapy (rRT) in patients with glioblastoma

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that data from a post-hoc analysis of the 22-week Phase 2 clinical study for its investigative drug candidate ralinepag, a next-generation, oral, selective and potent prostacyclin receptor agonist in development for the treatment of pulmonary arterial hypertension (PAH), will be presented at the International Society for Heart and Lung Transplantation (ISHLT) 2018 Annual Meeting

Thermo Fisher Scientific announced the Thermo Scientific Krios G3i cryo-electron microscope (cryo-EM) received a 2018 Edison Awards gold medal.

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Friday, May 4, 2018 at 8:30 a.m. ET to discuss financial results from the first quarter ended March 31, 2018.

HBI Solutions has partnered with the Koble Group to make HBI’s leading risk management software accessible for participants of Koble Group’s health information exchange.